INTEGER HOLDINGS CORPORATION Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
INTEGER HOLDINGS CORPORATION (ITGR) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $200.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-02-23
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2024-09-27 was $300.00K, a 90.91% decline year-over-year.
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-12-31 was $200.00K.
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-09-29 was $3.30M.
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-12-31 was $5.20M, a 1200.00% increase year-over-year.
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $200.00K, a 96.15% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $5.20M.
- INTEGER HOLDINGS CORPORATION equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $100.00K.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month as first filed | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $200.00K 10-K · filed 2026-02-23 | ||||
| 2024-09-27 | $300.00K 10-Q · filed 2025-10-23 | ||||
| 2023-12-31 | $200.00K 10-K · filed 2025-02-20 | $5.20M 10-K · filed 2024-02-20 | $3.50M derived: sum of 2 quarters · filed 2025-02-20 | $5.20M 10-K · filed 2026-02-23 | |
| 2023-09-29 | $3.30M 10-Q · filed 2024-10-24 | ||||
| 2021-12-31 | $5.20M 10-K · filed 2025-02-20 | $100.00K 10-K · filed 2023-02-21 | $100.00K 10-K · filed 2022-02-22 | ||
| 2020-12-31 | $400.00K 10-K · filed 2023-02-21 | ||||
| 2019-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2019-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | |||
| 2019-03-29 | $0.00 10-Q · filed 2019-05-03 | ||||
| 2018-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2018-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | |||
| 2018-03-30 | $0.00 10-Q · filed 2019-05-03 | ||||
| 2017-09-29 | $0.00 10-Q · filed 2018-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |